Alpha Teknova, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Last report0 of 4 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Alpha Teknova, Inc.
7.36
+0.35 · +4.92%
post 7.36 0.00%
+16.40%
vs ±20.7% implied · ×0.79
shaded = implied · ▲▼ = realized
Bull1
Bear2
| Manager | Value | % base | |
|---|---|---|---|
| Royce & | $9.4M | 18.24% | +55.39% |
| Vanguardindex-like | $9.2M | 17.72% | +265.27% |
| Roubaix Capital | $9.0M | 17.34% | −16.09% |
| BlackRockindex-like | $5.0M | 9.66% | +22.74% |
| UBS | $3.6M | 6.94% | +94.35% |
| Manager | Value | % base | |
|---|---|---|---|
| Royce & | $9.4M | 18.24% | +55.39% |
| Vanguardindex-like | $9.2M | 17.72% | +265.27% |
| Roubaix Capital | $9.0M | 17.34% | −16.09% |
| BlackRockindex-like | $5.0M | 9.66% | +22.74% |
| UBS | $3.6M | 6.94% | +94.35% |
Same SIC code · 6
Same SEC industry code: Idexx Laboratories Inc, Lantheus Holdings, Inc., Celldex Therapeutics, Inc. and 3 more; of Alpha Teknova, Inc.'s 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: Idexx Laboratories Inc, Lantheus Holdings, Inc., Celldex Therapeutics, Inc. and 3 more; of Alpha Teknova, Inc.'s 6 closest co-movers, none share that code.
Annual filing, covered
10-K parsed · Mar 2 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 2 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
Tall tick = annual report · Source: EDGAR
Expected move
Inputs8Q avg ±7.3%·×3.00·rich
straddle ±22.3%
spot 7.34exp Nov 20ATM strike 7.5ATM straddle 1.93IV 151%